MedTrace Logo

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

NCT04097067 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2024-08-27

No results posted yet for this study

Summary

This trial studies the effectivity of low-dose radiation therapy with 10x2Gy for the treatment of patients with stage I-II stomach or duodenal Lymphoma (Marginal Zone or Follicular)

Conditions

  • Follicular Lymphoma (Gastric or Duodenal)
  • Marginal Zone Lymphoma (Gastric or Duodenal)

Interventions

RADIATION

Radiation Therapy

Low dose radiotherapy with 20 Gy (10x2Gy)

Sponsors & Collaborators

  • International Lymphoma Radiation Oncology Group (ILROG)

    collaborator UNKNOWN

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Prof. Dr. H. Th. Eich · Department of Radiation Oncology University Hospital Muenster

  • Priv. Doz. Dr. G. Reinartz · Department of Radiation Oncology University Hospital Muenster

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097067 on ClinicalTrials.gov